MGC Diagnostics (MGCD) Reports Q3 EPS of $0.80

Go back to MGC Diagnostics (MGCD) Reports Q3 EPS of $0.80

MGC Diagnostics Corporation Reports Fiscal 2015 Third Quarter Results

September 10, 2015 4:01 PM EDT

SAINT PAUL, Minn., Sept. 10, 2015 /PRNewswire/ -- MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today reported financial results for the third quarter ended July 31, 2015.

2015 third quarter domestic equipment, supplies and accessories revenues were $5.2 million, compared to $3.9 million the 2014 third quarter, a 32.4% increase. During the quarter, competitive account conversions totaled 14 accounts, or $614,000 in revenue, compared to 10 accounts, or $620,000 in revenue for the same quarter last year, and MediSoft contributed domestic revenues of $111,000 from its U.S. distributor. Excluding the effect of revenues from competitive conversions and domestic... More